Central cardiovascular effects of narcotic analgesics and enkephalins in rats

British Journal of Pharmacology
M BelletH Schmitt

Abstract

1. The cardiovascular effects of morphine, fentanyl, [D-Ala2]-met-enkephalinamide were analyzed after intracisternal injection in anaesthetized rats. PaO2 was measured as an index of respiratory function. 2. At low doses in spontaneously breathing rats, morphine, fentanyl and [D-Ala2]-met-enkephalinamide induced a pressor response with slight tachycardia and no significant change in PaO2. 3. The pressor response appeared to be due to activation of opiate receptors and mediated through the sympathetic nervous system. 4. High doses of morphine and [D-Ala2]-met-enkephalinamide induced a biphasic effect with a secondary hypotension associated with bradycardia in spontaneously breathing rats. A marked reduction in PaO2 was found during the depressor phase. 5. High doses of [D-Ala2]-met-enkephalinamide produced only a pressor response in artificially-ventilated rats with no signs of secondary hypotension. 6. Our data support the idea that morphinomimetic agents are centrally pressor at low doses in the rat. The respiratory depression observed with high doses may be the cause of hypotension.

References

Apr 1, 1979·European Journal of Pharmacology·S R ChildersS H Synder
Nov 1, 1977·European Journal of Pharmacology·M LaubieG Remond
Nov 1, 1974·European Journal of Pharmacology·W De Jong

❮ Previous
Next ❯

Citations

Jan 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·R M QuockF J Kouchich
Jan 1, 1992·Biulleten' eksperimental'noĭ biologii i meditsiny·R A KrasnoperovN E Proshutina
Aug 1, 1988·Biulleten' eksperimental'noĭ biologii i meditsiny·E A Martynova, O S Medvedev
Nov 19, 1982·European Journal of Pharmacology·H NakamuraM Shimizu
Mar 26, 1982·European Journal of Pharmacology·G SanderD Coy
Oct 14, 1983·European Journal of Pharmacology·T BaumD M Desiderio
Apr 2, 1985·European Journal of Pharmacology·K InoueJ O Arndt
Nov 1, 1989·Clinical and Experimental Pharmacology & Physiology·H Wong-Dusting, M J Rand
Dec 1, 1991·Clinical and Experimental Pharmacology & Physiology·E Widy-Tyszkiewicz, A Członkowski
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·X M WangJ P Coghlan
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·J L ReidM A Petty
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·R E LangD Ganten
May 1, 1985·Progress in Cardiovascular Diseases·M W JohnsonC S Wilcox
Sep 1, 1981·British Journal of Pharmacology·J L MontastrucF Morales-Olivas
Mar 1, 1988·Journal of Autonomic Pharmacology·J Roquebert, C Delgoulet
Oct 1, 1983·International Journal of Peptide and Protein Research·C AmarH Schmitt
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·T Baum, F T Becker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.